Pharmaceutical Maker Recalls Drug Over Undeclared Anti-Hypertensive Drug

May 2020

Christine Blank

Studysummary A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

We don't know much about this study yet.

Read the full study on formularywatch.com →

Discuss this study in the Community →

Similar research 5

Citalopram And Finasteride With Lot Number FI0510058-A Voluntarily Recalled By Greenstone Due To Labeling Error Reactions Weekly · 2011
Reporting on Adverse Clinical Events Clin-Alert · 2015
Med Check Psychiatric News · 2011
Anaphylactic Shock Due to Intravenous Amiodarone; Delusional Parasitosis Associated with Donepezil; Connubial Androgenetic Alopecia; Ciprofloxacin-Induced Torsade de Pointes; Postvaccination Miller Fisher Syndrome; Life-Threatening Anaphylactoid Shock Caused by Recombinant Tissue Plasminogen Activator; Thiazide-Induced Hyponatremia Hospital Pharmacy · 2012
Drug-Related Lipid Metabolism Abnormalities: A Real-World Pharmacovigilance Exploratory Analysis Based on U.S. FDA Adverse Event Reporting System (FAERS) Nutrición Hospitalaria · 2026

Related Community Posts Join

6 / 1000+ results

community Why are there no proper phase 3 trials for RU

in Chat 4 upvotes 6 months ago

RU58841 lacks FDA approval due to financial and safety concerns, including potential cardiological side effects. The company abandoned further research, and users report adverse effects like heart palpitations and gynecomastia.

community Pyrilutamide / KX-826 | Discussion EU

4 upvotes 3 years ago

The conversation is about a user expressing concerns over the safety of a new drug called Pyrilutamide (also known as KX-826) for hair loss. The user will only trust the drug if it's permitted by EU regulations and sold by a reputable company.

community Update from December's Pyrilutamide GB?

13 upvotes 4 years ago

Participants discussed hair loss treatments, specifically Pyrilutamide, with some experiencing side effects like heart palpitations and anxiety. There is uncertainty about the drug's effectiveness, and a new group buy is planned with a different lab due to concerns about purity.

community Extreme caution: my experience using Ru58841 only once

in Treatment 10 upvotes 1 year ago

An 18-year-old experienced severe side effects, including heart palpitations and high blood pressure, after using RU58841 once, leading to a referral to cardiology for suspected left ventricular hypertrophy. The user regrets using RU58841 and seeks advice on recovery, while others suggest preexisting conditions or genetic predispositions may be factors.

community Here's why Pryiltamide "failed" phase 3 trials and marketed as a cosmetic

in Chat 8 upvotes 2 years ago

KX-826 failed Phase III trials due to high placebo effects, patient compliance issues, COVID-19 side effects, and detection method deviations. KX-826 is now marketed as a cosmetic and approved for combination with Minoxidil.

community RU58841 - Side Effects - Day 4: Chest Pain & Tightness, Bloodshot Eyes and some sort of inflammation/irritation on my throat.

8 upvotes 5 years ago

RU58841 caused chest tightness, throat irritation, and headaches, leading the user to stop its use. The user plans to restart with a lower dose if symptoms fully disappear but remains cautious due to anxiety and side effects.